LAB

Standard Biotools
$0.69
−$0.04 (−5.09%)Sep 10, 2026
2.6FairMoatMint rating

MoatMint rates Standard Biotools (LAB) 2.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.1 out of 10.

Key metrics

The numbers that frame LAB today
Market cap
$270.88M
P/E (TTM)
3.2
EV / FCF
-0.4
Gross margin
50.5%
EV / Sales
0.3
ROIC
13.8%
Div yield
0%
Debt / equity
0.1
52wk Low
$0.63
52wk High
$1.72

LAB stock rating

How LAB scores on quality, value, growth, momentum and financial health
2.6out of 10
Fair overallNeutral business, fair price
Quality2.1
Growth2.8
Momentum1.7
Value5.5
Financial Health9.1

Growth

Revenue and earnings trend for LAB
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about LAB
Is Standard Biotools a good buy?
No. Standard Biotools has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Standard Biotools is selling at a fair price.
What is the market capitalization of LAB?
Standard Biotools's market capitalization is $270.88M.
What is the P/E ratio for LAB stock?
Standard Biotools's current P/E ratio is 3.2.
What is the 52-week high for LAB stock?
The 52-week high for Standard Biotools is $1.72. The current close of $0.69 is 59.9% below that high.
What is the 52-week low for LAB stock?
The 52-week low for Standard Biotools is $0.63. The current close of $0.69 is 9.5% above that low.
Does LAB stock pay dividends?
Standard Biotools does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LAB?
Standard Biotools's Debt / Equity ratio is 0.05.